• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. ENDOSCOPE REPROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. ENDOSCOPE REPROCESSOR Back to Search Results
Model Number OER-PRO
Device Problem Failure to Disinfect (1175)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/07/2022
Event Type  malfunction  
Manufacturer Narrative
In speaking with olympus technical support via the phone, the customer was advised the disinfectant had to be changed every five (5) days or roughly every thirty-five (35) cycles.The reporter was the infection control person at the facility.The reporter did not provide the cycle count and software version at the time of the call.The reporter was sent an updated email with a copy of olympus instruction for use (ifu) indicating if the acecide-c goes past five (5) days without being changed, results in non-conformance per the ifu.All scopes involved were reprocessed again according to ifu compliance.An olympus endoscopy support specialist (ess) has been dispatched to observe the user facility¿s reprocessing practices from start to finish and provide a reprocessing in-service training, if necessary, to correct and address any reprocessing deviations.The subject device referenced in this report was not returned for evaluation.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation.
 
Event Description
The customer reported to olympus, the disinfectant in the oer-pro had gone past the five (5) day mark.The reporter stated the facility had performed twelve (12) reprocessing cycles that day.Twelve (12) scopes were reprocessed insufficiently or incorrectly.One cycle with two (2) evis exera ii colonovideoscopes had to be reprocessed a second time as the first time the lid was open and an e31 error message (open lid) was presented.The technician who performed the efficacy tests before each cycle had logged that all of scopes had passed the tests.Each scope except for the evis exera ii colonovideoscope had been used once on a patient.No patient injury or procedure impact reported.This complaint is related to patient identifiers: (b)(6) (gif-h180j / sn: (b)(4)), (b)(6) (gif-h180j / sn: (b)(4)), (b)(6) (gif-h180j / sn: (b)(4)), (b)(6) (cf-h180al / sn: (b)(4)), (b)(6) (cf-h180al / sn: (b)(4)), (b)(6) (cf-h180al / sn: (b)(4)), (b)(6) (pcf-q180al / sn: (b)(4)), (b)(6) (cf-h180al / sn: (b)(4)), (b)(6) (cf-180al / sn: (b)(4)), (b)(6) (gif-h180j / sn: (b)(4)), (b)(6) (cf-q180al / sn: (b)(4)), (b)(6) (pcf-h180al / sn: (b)(4)).
 
Manufacturer Narrative
This supplemental report is being submitted to provide a summary of the olympus endoscopy support specialist (ess) visit.An olympus endoscopy support specialist (ess) had been dispatched to observe the user facility¿s reprocessing practices from start to finish and provide a reprocessing in-service training, if necessary, to correct and address any reprocessing deviations.The olympus endoscopy support specialist (ess) noted that during the reprocessing in-service, no breaches were noted.The customer performed all the reprocessing steps according to the olympus instructions for use (ifu).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the approved final investigation.A review of the device history record found no deviations that could have caused or contributed to the reported issue.Based on the results of the investigation, and since the device was not returned for evaluation, the definitive root cause of the disinfectant replacement issue could not be determined.It is possible that the issue occurred due to user error in management of the disinfectant solution and did not understand the period to replace acecide.The instruction manual identifies the following verbiage, which may have prevented the phenomenon:¿oer-pro operation manual 6.4 setting the disinfectant solution counter ·note on the disinfectant solution counter function.Acecide-c product overview ·reuse period up to 5 days.¿ olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOSCOPE REPROCESSOR
Type of Device
ENDOSCOPE REPROCESSOR
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer Contact
masaharu hirose
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8-520
JA   965-8520
426422891
MDR Report Key15524609
MDR Text Key306508376
Report Number9610595-2022-02451
Device Sequence Number1
Product Code FEB
UDI-Device Identifier04953170258589
UDI-Public04953170258589
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K103264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberOER-PRO
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/08/2022
Initial Date FDA Received10/01/2022
Supplement Dates Manufacturer Received10/03/2022
12/09/2022
Supplement Dates FDA Received10/26/2022
01/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/26/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-